Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40054917

about

Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells.Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter Characteristic variation of α-fetoprotein DNA nanometer-range irradiated by iodine-125.Adrenal gland infection by serotype 5 adenovirus requires coagulation factors.Generation of a tumor- and tissue-specific episomal non-viral vector system.Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Lung microenvironment promotes the metastasis of human hepatocellular carcinoma cells to the lungs.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.The Na+/I- symporter (NIS): mechanism and medical impact.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Targeted RNA interference for hepatic fibrosis.SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.Cancer imaging: Gene transcription-based imaging and therapeutic systems.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Gene therapy of pancreatic cancer targeting the K-Ras oncogene.In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma.The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.Hypoxia-inducible enhancer/alpha-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.

P2860

Q26741197-CEB969B9-269D-4411-A505-D198D29E9293 Q26772332-907D0821-5D4E-4311-8DFE-065D6E5D021F Q27023157-D14D484B-D979-4ACE-BA14-E50929279EA4 Q33480990-018B94B3-4F48-4A0B-84C2-7A32C2686D72 Q33603806-32FB486F-39BE-46B5-96CC-F623ED34CAD1 Q33670033-94F8DF5C-B4AA-4659-885D-611373BDE9A6 Q33704207-0A237C22-920A-42C9-A05F-0C74102DFF11 Q33920953-6E722850-74B9-464E-83F6-AA9F43034612 Q34130093-7414A965-1BC7-4B80-AB34-8A03A0FB9A92 Q34209727-C1A9FFC5-989D-4189-A0ED-401256225B49 Q34303955-F83C459C-848C-47FE-8790-55F577BEF168 Q34512455-77E88F8D-168E-42EC-8FE5-25610E5CFDB9 Q34662320-9ED1A223-1486-4539-B33A-8CA33F487B9F Q34701038-5A5ABFFE-0C3F-40B7-AF3A-96013E13EC54 Q34756391-0E4EC431-7F57-4510-A502-F000C6859B4D Q34757186-EF92D601-05AA-4F42-8255-857425767D31 Q35068110-F42139F6-90B5-4920-A047-BA622B1C3FB8 Q35238289-DCC264B6-62EA-4BE8-8136-F4FB99CE3339 Q35575677-076CF36E-FCF0-4B3D-A384-DDA196513B32 Q35612571-51507D7E-C1C0-4F3B-99F3-DD44E769DED7 Q35959009-8B697208-498A-4B9A-AD12-240DA869D004 Q36128415-1AEDB63C-3F37-41D2-9941-46670BDFD7B3 Q36720696-E579E51F-2158-4AA4-B230-47FE554111F6 Q37494004-E56952DB-07C7-4F63-AA6C-751524BCB393 Q37564872-89C3B77E-5F52-4025-A67C-5AF76608B5FE Q37590368-B343334C-E7A1-44AC-BBF4-A2E64EC6D3D8 Q37590840-ABCEF7FB-405C-4882-9D2A-8154E25D773F Q37691930-547484D8-CAD9-492B-8164-D666E8BFBABB Q37986315-5D5ABF0B-11C5-43E5-A67D-0B4F01FB6581 Q38772380-232697D9-B577-4140-BD50-3C86BEA4EF13 Q39253164-D46A0EC1-6105-4489-A7F2-BD2E86B89A58 Q39320280-80811406-873F-474D-8798-79A42DC00E5D Q39386060-8CD2C444-C524-4DC1-8755-BE4A5A73AD6B Q39499511-FDF91CB9-D231-440E-941C-097CD4B6E6B6 Q40045104-6BF80297-3AA4-48DD-83C5-F8212DC16332 Q45326571-90848467-FC6B-41AB-A231-FCFCF6EF4AF3 Q45866837-DCBED556-C159-4637-9ED2-00000B34CA49

P2860

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40054917

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Alpha-fetoprotein promoter-tar ...... y of hepatocellular carcinoma.

@en

type

label

Alpha-fetoprotein promoter-tar ...... y of hepatocellular carcinoma.

@en

prefLabel

Alpha-fetoprotein promoter-tar ...... y of hepatocellular carcinoma.

@en

P1433

Q40054917-8BCCDC0F-1C5A-4EF8-9551-42DB231AB10A

P1476

Q40054917-CE3874C7-586F-4D44-A6F1-14341A6D7856

P2093

Q40054917-2257320E-57C5-4DE7-856F-8E49E55B2B0C

Q40054917-28FCCB87-74AA-4210-9022-F832848F2844

Q40054917-58D78BBC-D762-4375-BE40-EB3A40491F7A

Q40054917-611E24CB-F555-4C10-BCE2-A0F1B7519DB8

Q40054917-62D6DF25-EBF1-4C0E-8696-635BC249F5EB

Q40054917-8727363B-D01D-47FE-9DB2-CA74834B4D03

Q40054917-9AAE1582-F586-4C90-8489-3E658291C615

Q40054917-9D447DF1-5F27-4220-9163-31DAE686C3B5

Q40054917-AF257045-FDB1-4A0F-8A92-CF8EF33454AA

Q40054917-D20BC956-2A47-4301-B5A0-041B55B27CEB

P2860

Q40054917-106A73A8-EB27-445E-92B2-ADB4D3653FE9

Q40054917-1CF6B157-03EA-4E87-98A9-F058614F9141

Q40054917-22306E5B-75F6-4401-AEE6-4AE2761C9E46

Q40054917-26C04DE4-B865-4907-9B46-869D7B4960BF

Q40054917-2C2D1959-8C82-48C1-B9C4-32144C60E5CD

Q40054917-575E746C-1E76-4077-9C9E-B2F1BB155951

Q40054917-62013575-E2F7-4DC7-B509-DC9324B12C1F

Q40054917-69D92DD4-8A4A-4F07-860C-12FA422CEE8C

Q40054917-6F49DF0F-E50C-4534-B4D0-7F1987E1E11C

Q40054917-7599ED51-2118-4733-9334-9C782E388836

P2888

Q40054917-D37F3FAF-EA4C-472F-A25A-B3627F07B5D7

P304

Q40054917-604F46F8-4BD7-41FC-B551-E070A34EFA04

P31

Q40054917-5AE72D0A-5CEF-4A0D-84C5-1C2C9B8AC042

P356

Q40054917-DEA36BD2-41AA-41E7-8834-3AA838D6173D

P433

Q40054917-1F6AE37A-B31F-46D3-88C3-665FF58FCAD8

P478

Q40054917-2F7743D2-AA2A-4CBB-9177-34494C4D4783

P577

Q40054917-0DF47B4B-E620-484D-9C18-5C49871AB42B

P5875

Q40054917-0D73ABE3-7E93-434D-AB5A-141A7CC569C4

P6179

Q40054917-0316BE15-D128-4A92-8884-B8DBC6372EDA

P698

Q40054917-BD9A98D0-4B9C-4803-81C5-270F7FCD86FA

P921

Q40054917-D1B19BE7-6FAF-475C-A05F-1DC88F3C2589

P356

P1433

P1476

Alpha-fetoprotein promoter-tar ...... y of hepatocellular carcinoma.

@en

P2093

Cengic N

http://www.w3.org/2001/XMLSchema#string

Geissler M

http://www.w3.org/2001/XMLSchema#string

Göke B

http://www.w3.org/2001/XMLSchema#string

Klutz K

http://www.w3.org/2001/XMLSchema#string

Mohr L

http://www.w3.org/2001/XMLSchema#string

Morris JC

http://www.w3.org/2001/XMLSchema#string

Senekowitsch-Schmidtke R

http://www.w3.org/2001/XMLSchema#string

Sharif Samani BR

http://www.w3.org/2001/XMLSchema#string

Spitzweg C

http://www.w3.org/2001/XMLSchema#string

Willhauck MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human sodium lodide symporter

The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance

Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter

Cloning and characterization of the thyroid iodide transporter

Management of hepatocellular carcinoma

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.

Estimating the world cancer burden: Globocan 2000.

The sodium iodide symporter: its pathophysiological and therapeutic implications.

In vivo imaging and tumor therapy with the sodium iodide symporter.

P2888

P304

214-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3303057

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5856400

http://www.w3.org/2001/XMLSchema#string

P6179

1046779161

http://www.w3.org/2001/XMLSchema#string

P698

17989705

http://www.w3.org/2001/XMLSchema#string

P921